OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Reporting Frequency of Ketoacidosis Events with Dapagliflozin from the European Spontaneous Reporting System: The DAPA-KETO Study
Gabriella di Mauro, Annamaria Mascolo, Mario Gaio, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 3, pp. 286-286
Open Access | Times Cited: 14
Gabriella di Mauro, Annamaria Mascolo, Mario Gaio, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 3, pp. 286-286
Open Access | Times Cited: 14
Showing 14 citing articles:
Insulin Resistance in Type 1 Diabetes: Pathophysiological, Clinical, and Therapeutic Relevance
Maria Apostolopoulou, Vaia Lambadiari, Michael Roden, et al.
Endocrine Reviews (2025)
Open Access | Times Cited: 2
Maria Apostolopoulou, Vaia Lambadiari, Michael Roden, et al.
Endocrine Reviews (2025)
Open Access | Times Cited: 2
Safety profile of sodium glucose co-transporter 2 (SGLT2) inhibitors: A brief summary
Annamaria Mascolo, Raffaella Di Napoli, Nunzia Balzano, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 53
Annamaria Mascolo, Raffaella Di Napoli, Nunzia Balzano, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 53
Ketoacidosis and SGLT2 Inhibitors: A Narrative Review
Carmela Morace, Giuseppe Lorello, Federica Bellone, et al.
Metabolites (2024) Vol. 14, Iss. 5, pp. 264-264
Open Access | Times Cited: 9
Carmela Morace, Giuseppe Lorello, Federica Bellone, et al.
Metabolites (2024) Vol. 14, Iss. 5, pp. 264-264
Open Access | Times Cited: 9
Dapagliflozin improves diabetic kidney disease by inhibiting ferroptosis through β-hydroxybutyrate production
Yan Tian, Chenxia Zhou, Qun Yan, et al.
Renal Failure (2025) Vol. 47, Iss. 1
Open Access | Times Cited: 1
Yan Tian, Chenxia Zhou, Qun Yan, et al.
Renal Failure (2025) Vol. 47, Iss. 1
Open Access | Times Cited: 1
Comparative efficacy of sodium glucose cotransporter-2 inhibitors in the management of type 2 diabetes mellitus: A real-world experience
Lubna Islam, Dhanya Jose, Mohammed Alkhalifah, et al.
World Journal of Diabetes (2024) Vol. 15, Iss. 3, pp. 463-474
Open Access | Times Cited: 4
Lubna Islam, Dhanya Jose, Mohammed Alkhalifah, et al.
World Journal of Diabetes (2024) Vol. 15, Iss. 3, pp. 463-474
Open Access | Times Cited: 4
Euglycemic Diabetic Ketoacidosis in a Patient Treated With Empagliflozin After Acute Myocardial Infraction
George Tournas, Argyro Papadopoulou, Polyxeni Manifava, et al.
American Journal of Therapeutics (2025)
Closed Access
George Tournas, Argyro Papadopoulou, Polyxeni Manifava, et al.
American Journal of Therapeutics (2025)
Closed Access
Managing Hospitalized Patients Taking SGLT2 Inhibitors: Reducing the Risk of Euglycemic Diabetic Ketoacidosis
Julia Selwyn, Ariana Pichardo‐Lowden
Diabetology (2023) Vol. 4, Iss. 1, pp. 86-92
Open Access | Times Cited: 9
Julia Selwyn, Ariana Pichardo‐Lowden
Diabetology (2023) Vol. 4, Iss. 1, pp. 86-92
Open Access | Times Cited: 9
Real-world safety and effectiveness of dapagliflozin in people living with type 1 diabetes in Spain: The Dapa-ON multicenter retrospective study
Marı́a Durán-Martinez, Sharona Azriel, Viyey Doulatram‐Gamgaram, et al.
Diabetes & Metabolism (2023) Vol. 50, Iss. 1, pp. 101501-101501
Open Access | Times Cited: 9
Marı́a Durán-Martinez, Sharona Azriel, Viyey Doulatram‐Gamgaram, et al.
Diabetes & Metabolism (2023) Vol. 50, Iss. 1, pp. 101501-101501
Open Access | Times Cited: 9
Safety of dapagliflozin and empagliflozin in cases with diabetes mellitus or/and heart failure: a retrospective pharmacovigilance study conducted on the eudravigilance database
Annamaria Mascolo, Alessia Zinzi, Mario Gaio, et al.
Pharmacological Reports (2024)
Closed Access | Times Cited: 1
Annamaria Mascolo, Alessia Zinzi, Mario Gaio, et al.
Pharmacological Reports (2024)
Closed Access | Times Cited: 1
Delayed euDKA Associated With Dapagliflozin After Pancreatitis
Gao Wu, Shuxie Wu, Jin Tang, et al.
Clinical Therapeutics (2023) Vol. 45, Iss. 7, pp. e167-e170
Closed Access | Times Cited: 2
Gao Wu, Shuxie Wu, Jin Tang, et al.
Clinical Therapeutics (2023) Vol. 45, Iss. 7, pp. e167-e170
Closed Access | Times Cited: 2
Sodium-glucose cotransporter–2 (SGLT2) inhibitors and the reporting of falls and fractures: an european pharmacovigilance analysis
Annamaria Mascolo, Concetta Rafaniello, Gabriella di Mauro, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 2
Annamaria Mascolo, Concetta Rafaniello, Gabriella di Mauro, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 2
Level of implementation of the pharmacovigilance program and its associated factors in health institutions in Valle del Cauca
Jobany Castro Espinosa, Hernán Estupiñán Cabrera, María Antonieta Pineda, et al.
Revista Colombiana de Ciencias Químico Farmacéuticas (2024) Vol. 53, Iss. 2, pp. 488-512
Open Access
Jobany Castro Espinosa, Hernán Estupiñán Cabrera, María Antonieta Pineda, et al.
Revista Colombiana de Ciencias Químico Farmacéuticas (2024) Vol. 53, Iss. 2, pp. 488-512
Open Access
GLP-1 Receptor Agonists and SGLT-2 Inhibitors as Adjuncts to Insulin in Type 1 Diabetes: Benefits and Concerns
George Dimitriadis, Vaia Lambadiari
The Journal of Clinical Endocrinology & Metabolism (2022) Vol. 108, Iss. 4, pp. e52-e53
Open Access | Times Cited: 1
George Dimitriadis, Vaia Lambadiari
The Journal of Clinical Endocrinology & Metabolism (2022) Vol. 108, Iss. 4, pp. e52-e53
Open Access | Times Cited: 1
Dapagliflozin associated with higher risk of ketoacidosis in T2DM patients
Reactions Weekly (2022) Vol. 1900, Iss. 1, pp. 6-6
Closed Access
Reactions Weekly (2022) Vol. 1900, Iss. 1, pp. 6-6
Closed Access
